Nadezhda Eberhart

Nadezhda Eberhart, MD, is a Senior Medical Director for Global Patient Safety in Autoimmune at Eli Lilly and Company. With a strong background in clinical research, they have led various roles in clinical trial management and operations across multiple therapeutic areas and geographies. Nadezhda has demonstrated expertise in ethics and compliance, having built and trained teams while supporting compliance initiatives across the Americas, Africa, the Middle East, and Asia. They began their medical career as a Clinical Researcher focusing on Autoimmune Diseases at Sheba Hospital and obtained their Doctor of Medicine degree from the Medical University-Varna.